Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0003873,
umls-concept:C0009498,
umls-concept:C0017243,
umls-concept:C0019054,
umls-concept:C0021017,
umls-concept:C0032334,
umls-concept:C0035448,
umls-concept:C0080103,
umls-concept:C0087111,
umls-concept:C0243072,
umls-concept:C0871261,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2603343,
umls-concept:C2911692
|
pubmed:issue |
1
|
pubmed:dateCreated |
1985-5-14
|
pubmed:abstractText |
Complement (C) activating rheumatoid factors (RF) were measured in 16 patients with rheumatoid arthritis (RA) by a simple haemolysis in gel (HIG) assay. IgM-RF, but not IgG-RF or IgA-RF, measured by an enzyme linked immuno-sorbent assay, were closely correlated with C activating RF (r = 0.86). In neither assay did the concentrations of RF appear to be directly related to C1 activation as expressed by serum concentrations of C1r-C1s-C1 inactivator complexes or of C4. In the sera, C1q binding substances, measured by C1q binding assay, were markedly correlated with C activating RF (r = 0.88), whereas C1q binding substances detected by the C1q deviation test were not. Treatment with podophyllotoxin derivatives for 6 months clearly reduced patients' RF concentrations. The decrease of IgG-RF, IgA-RF and IgM-RF was significantly more pronounced than that of the IgG, IgA and IgM concentrations, respectively.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0392-856X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
29-37
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3884203-Adult,
pubmed-meshheading:3884203-Aged,
pubmed-meshheading:3884203-Antigen-Antibody Complex,
pubmed-meshheading:3884203-Arthritis, Rheumatoid,
pubmed-meshheading:3884203-Complement Activation,
pubmed-meshheading:3884203-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:3884203-Female,
pubmed-meshheading:3884203-Hemolytic Plaque Technique,
pubmed-meshheading:3884203-Humans,
pubmed-meshheading:3884203-Immunoglobulins,
pubmed-meshheading:3884203-Male,
pubmed-meshheading:3884203-Middle Aged,
pubmed-meshheading:3884203-Podophyllotoxin,
pubmed-meshheading:3884203-Rheumatoid Factor
|
pubmed:articleTitle |
Complement activating rheumatoid factors in rheumatoid arthritis studied by haemolysis in gel: relation to antibody class and response to treatment with podophyllotoxin derivatives.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|